| Year |
Citation |
Score |
| 2024 |
Walker L, Simpson H, Thomas AJ, Attems J. Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease. Acta Neuropathologica Communications. 12: 28. PMID 38360761 DOI: 10.1186/s40478-023-01714-7 |
0.388 |
|
| 2024 |
Malik N, Miah MU, Galgani A, McAleese K, Walker L, LeBeau FE, Attems J, Outeiro TF, Thomas A, Koss DJ. Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic change. Acta Neuropathologica. 147: 40. PMID 38353753 DOI: 10.1007/s00401-024-02691-4 |
0.385 |
|
| 2023 |
Walker L, Attems J. Prevalence of Concomitant Pathologies in Parkinson's Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms. Journal of Parkinson's Disease. PMID 38143370 DOI: 10.3233/JPD-230154 |
0.306 |
|
| 2023 |
Katanga JA, Hamilton CA, Walker L, Attems J, Thomas AJ. Age-related hearing loss and dementia-related neuropathology: An analysis of the United Kingdom brains for dementia research cohort. Brain Pathology (Zurich, Switzerland). e13188. PMID 37551936 DOI: 10.1111/bpa.13188 |
0.32 |
|
| 2022 |
Nelson PT, Lee EB, Cykowski MD, Alafuzoff I, Arfanakis K, Attems J, Brayne C, Corrada MM, Dugger BN, Flanagan ME, Ghetti B, Grinberg LT, Grossman M, Grothe MJ, Halliday GM, et al. LATE-NC staging in routine neuropathologic diagnosis: an update. Acta Neuropathologica. PMID 36512061 DOI: 10.1007/s00401-022-02524-2 |
0.418 |
|
| 2022 |
Nelson PT, Brayne C, Flanagan ME, Abner EL, Agrawal S, Attems J, Castellani RJ, Corrada MM, Cykowski MD, Di J, Dickson DW, Dugger BN, Ervin JF, Fleming J, Graff-Radford J, et al. Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts. Acta Neuropathologica. PMID 35697880 DOI: 10.1007/s00401-022-02444-1 |
0.353 |
|
| 2021 |
Hamilton CA, Matthews FE, Erskine D, Attems J, Thomas AJ. Neurodegenerative brain changes are associated with area deprivation in the United Kingdom: findings from the Brains for Dementia Research study. Acta Neuropathologica Communications. 9: 198. PMID 34924033 DOI: 10.1186/s40478-021-01301-8 |
0.327 |
|
| 2021 |
Farrell K, Kim S, Han N, Iida MA, Gonzalez EM, Otero-Garcia M, Walker JM, Richardson TE, Renton AE, Andrews SJ, Fulton-Howard B, Humphrey J, Vialle RA, Bowles KR, de Paiva Lopes K, ... ... Attems J, et al. Genome-wide association study and functional validation implicates JADE1 in tauopathy. Acta Neuropathologica. PMID 34719765 DOI: 10.1007/s00401-021-02379-z |
0.356 |
|
| 2021 |
McAleese KE, Miah M, Graham S, Hadfield GM, Walker L, Johnson M, Colloby SJ, Thomas AJ, DeCarli C, Koss D, Attems J. Frontal white matter lesions in Alzheimer's disease are associated with both small vessel disease and AD-associated cortical pathology. Acta Neuropathologica. PMID 34608542 DOI: 10.1007/s00401-021-02376-2 |
0.385 |
|
| 2021 |
McAleese KE, Colloby SJ, Thomas AJ, Al-Sarraj S, Ansorge O, Neal J, Roncaroli F, Love S, Francis PT, Attems J. Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33663011 DOI: 10.1002/alz.12291 |
0.3 |
|
| 2021 |
Oliveira FPM, Walker Z, Walker RWH, Attems J, Castanheira JC, Silva Â, Oliveira C, Vaz S, Silva M, Costa DC. I FP-CIT SPECT in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease: a new quantitative analysis of autopsy confirmed cases. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 33542085 DOI: 10.1136/jnnp-2020-324606 |
0.371 |
|
| 2021 |
Attems J, Toledo JB, Walker L, Gelpi E, Gentleman S, Halliday G, Hortobagyi T, Jellinger K, Kovacs GG, Lee EB, Love S, McAleese KE, Nelson PT, Neumann M, Parkkinen L, et al. Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathologica. PMID 33399945 DOI: 10.1007/s00401-020-02255-2 |
0.364 |
|
| 2020 |
Hannon E, Shireby GL, Brookes K, Attems J, Sims R, Cairns NJ, Love S, Thomas AJ, Morgan K, Francis PT, Mill J. Genetic risk for Alzheimer's disease influences neuropathology via multiple biological pathways. Brain Communications. 2: fcaa167. PMID 33376986 DOI: 10.1093/braincomms/fcaa167 |
0.37 |
|
| 2020 |
Walker JM, Richardson TE, Farrell K, Iida MA, Foong C, Shang P, Attems J, Ayalon G, Beach TG, Bigio EH, Budson A, Cairns NJ, Corrada M, Cortes E, Dickson DW, et al. Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy. Journal of Neuropathology and Experimental Neurology. PMID 33367843 DOI: 10.1093/jnen/nlaa153 |
0.33 |
|
| 2020 |
Liu KY, Reeves S, McAleese KE, Attems J, Francis P, Thomas A, Howard R. Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease. Brain : a Journal of Neurology. PMID 33188391 DOI: 10.1093/brain/awaa315 |
0.346 |
|
| 2020 |
McAleese KE, Walker L, Erskine D, Johnson M, Koss D, Thomas AJ, Attems J. Concomitant LATE-NC in Alzheimer's disease is not associated with increased tau or amyloid-β pathological burden. Neuropathology and Applied Neurobiology. PMID 32896913 DOI: 10.1111/Nan.12664 |
0.508 |
|
| 2020 |
Michael J, Unger MS, Poupardin R, Schernthaner P, Mrowetz H, Attems J, Aigner L. Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer's Disease mice. Acta Neuropathologica Communications. 8: 129. PMID 32771067 DOI: 10.1186/S40478-020-00989-4 |
0.42 |
|
| 2020 |
Koss DJ, Bondarevaite O, Adams S, Leite M, Giorgini F, Attems J, Outeiro TF. RAB39B is redistributed in dementia with lewy bodies and is sequestered within Aβ plaques and lewy bodies. Brain Pathology (Zurich, Switzerland). PMID 32762091 DOI: 10.1111/Bpa.12890 |
0.52 |
|
| 2020 |
Hatton C, Reeve A, Lax NZ, Blain A, Ng YS, El-Agnaf O, Attems J, Taylor JP, Turnbull D, Erskine D. Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies. Acta Neuropathologica Communications. 8: 103. PMID 32646480 DOI: 10.1186/S40478-020-00985-8 |
0.348 |
|
| 2020 |
Neddens J, Daurer M, Flunkert S, Beutl K, Loeffler T, Walker L, Attems J, Hutter-Paier B. Correlation of pyroglutamate amyloid β and ptau Ser202/Thr205 levels in Alzheimer's disease and related murine models. Plos One. 15: e0235543. PMID 32645028 DOI: 10.1371/Journal.Pone.0235543 |
0.455 |
|
| 2020 |
Unger MS, Li E, Scharnagl L, Poupardin R, Altendorfer B, Mrowetz H, Hutter-Paier B, Weiger TM, Heneka MT, Attems J, Aigner L. CD8 T-cells infiltrate Alzheimer's disease brains and regulate neuronal- and synapse-related gene expression in APP-PS1 transgenic mice. Brain, Behavior, and Immunity. PMID 32479993 DOI: 10.1016/J.Bbi.2020.05.070 |
0.362 |
|
| 2020 |
Fayyad M, Erskine D, Majbour NK, Vaikath NN, Ghanem SS, Sudhakaran IP, Abdesselem H, Lamprokostopoulou A, Vekrellis K, Morris CM, Attems J, El-Agnaf OMA. Investigating the Presence of Doubly-phosphorylated α-Synuclein at Tyrosine 125 and Serine 129 In Idiopathic Lewy Body Diseases. Brain Pathology (Zurich, Switzerland). PMID 32324926 DOI: 10.1111/Bpa.12845 |
0.376 |
|
| 2020 |
Marschallinger J, Altendorfer B, Rockenstein E, Holztrattner M, Garnweidner-Raith J, Pillichshammer N, Leister I, Hutter-Paier B, Strempfl K, Unger MS, Chishty M, Felder T, Johnson M, Attems J, Masliah E, et al. The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 32072462 DOI: 10.1007/S13311-020-00836-3 |
0.359 |
|
| 2020 |
Owasil R, O'Neill R, Keable A, Nimmo J, MacGregor Sharp M, Kelly L, Saito S, Simpson JE, Weller RO, Smith C, Attems J, Wharton SB, Yuen HM, Carare RO. The Pattern of AQP4 Expression in the Ageing Human Brain and in Cerebral Amyloid Angiopathy. International Journal of Molecular Sciences. 21. PMID 32059400 DOI: 10.3390/Ijms21041225 |
0.376 |
|
| 2020 |
Ling H, Gelpi E, Davey K, Jaunmuktane Z, Mok KY, Jabbari E, Simone R, R'Bibo L, Brandner S, Ellis MJ, Attems J, Mann D, Halliday GM, Al-Sarraj S, Hedreen J, et al. Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates. Acta Neuropathologica. PMID 31950334 DOI: 10.1007/S00401-019-02119-4 |
0.404 |
|
| 2019 |
Walker L, Attems J. Relationship Between Tau, β Amyloid and α-Synuclein Pathologies. Advances in Experimental Medicine and Biology. 1184: 169-176. PMID 32096037 DOI: 10.1007/978-981-32-9358-8_14 |
0.443 |
|
| 2019 |
Prokopenko I, Miyakawa G, Zheng B, Heikkinen J, Petrova Quayle D, Udeh-Momoh C, Claringbould A, Neumann J, Haytural H, Kaakinen MA, Loizidou E, Meissner E, Bertram L, Gveric DO, ... ... Attems J, et al. Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE-ε4/TOMM40 long poly-T repeat allele variants. Alzheimer's & Dementia (New York, N. Y.). 5: 814-824. PMID 31788537 DOI: 10.1016/J.Trci.2019.08.005 |
0.494 |
|
| 2019 |
Erskine D, Reeve AK, Polvikoski T, Schaefer AM, Taylor RW, Lax NZ, El-Agnaf O, Attems J, Gorman GS, Turnbull DM, Ng YS. Lewy body pathology is more prevalent in older individuals with mitochondrial disease than controls. Acta Neuropathologica. PMID 31781911 DOI: 10.1007/S00401-019-02105-W |
0.322 |
|
| 2019 |
Ivashko-Pachima Y, Hadar A, Grigg I, Korenková V, Kapitansky O, Karmon G, Gershovits M, Sayas CL, Kooy RF, Attems J, Gurwitz D, Gozes I. Discovery of autism/intellectual disability somatic mutations in Alzheimer's brains: mutated ADNP cytoskeletal impairments and repair as a case study. Molecular Psychiatry. PMID 31664177 DOI: 10.1038/S41380-019-0563-5 |
0.361 |
|
| 2019 |
Alexandris AS, Walker L, Liu AKL, McAleese K, Johnson M, Pearce RKB, Gentleman SM, Attems J. Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer's disease and Lewy body disorders. Neuropathology and Applied Neurobiology. PMID 31454423 DOI: 10.1111/Nan.12577 |
0.804 |
|
| 2019 |
Patterson L, Firbank MJ, Colloby SJ, Attems J, Thomas AJ, Morris CM. Neuropathological Changes in Dementia With Lewy Bodies and the Cingulate Island Sign. Journal of Neuropathology and Experimental Neurology. PMID 31271438 DOI: 10.1093/Jnen/Nlz047 |
0.436 |
|
| 2019 |
Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Chui HC, Fardo DW, Flanagan ME, Halliday G, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain : a Journal of Neurology. PMID 31039256 DOI: 10.1093/Brain/Awz099 |
0.455 |
|
| 2019 |
Walker L, Stefanis L, Attems J. Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies - current issues and future directions. Journal of Neurochemistry. PMID 30892688 DOI: 10.1111/Jnc.14698 |
0.431 |
|
| 2019 |
Walker L, McAleese KE, Erskine D, Attems J. Neurodegenerative Diseases and Ageing. Sub-Cellular Biochemistry. 91: 75-106. PMID 30888650 DOI: 10.1007/978-981-13-3681-2_4 |
0.467 |
|
| 2019 |
Tilley BS, Smith C, Pavese N, Attems J. Rare histotype of sporadic Creutzfeldt-Jakob disease, clinically suspected as corticobasal degeneration. Bmj Case Reports. 12. PMID 30850568 DOI: 10.1136/Bcr-2018-228305 |
0.421 |
|
| 2019 |
Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I. Dementia with Lewy bodies: an update and outlook. Molecular Neurodegeneration. 14: 5. PMID 30665447 DOI: 10.1186/S13024-019-0306-8 |
0.398 |
|
| 2018 |
Patterson L, Rushton SP, Attems J, Thomas AJ, Morris CM. Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders. Brain Pathology (Zurich, Switzerland). PMID 30582885 DOI: 10.1111/Bpa.12697 |
0.335 |
|
| 2018 |
McAleese KE, Graham S, Dey M, Walker L, Erskine D, Johnson M, Johnston E, Thomas AJ, McKeith IG, DeCarli C, Attems J. Extravascular fibrinogen in the white matter of Alzheimer's disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer's disease. Brain Pathology (Zurich, Switzerland). PMID 30485582 DOI: 10.1111/Bpa.12685 |
0.506 |
|
| 2018 |
Lloyd JJ, Petrides G, Donaghy PC, Colloby SJ, Attems J, O'Brien JT, Roberts G, Thomas AJ. A new visual rating scale for Ioflupane imaging in Lewy body disease. Neuroimage. Clinical. 20: 823-829. PMID 30268991 DOI: 10.1016/J.Nicl.2018.09.012 |
0.366 |
|
| 2018 |
Nicolas G, Acuna-Hidalgo R, Keogh MJ, Quenez O, Steehouwer M, Lelieveld S, Rousseau S, Richard AC, Oud MS, Marguet F, Laquerrière A, Morris CM, Attems J, Smith C, Ansorge O, et al. Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30114415 DOI: 10.1016/J.Jalz.2018.06.3056 |
0.407 |
|
| 2018 |
Chai YL, Chong JR, Weng J, Howlett D, Halsey A, Lee JH, Attems J, Aarsland D, Francis PT, Chen CP, Lai MKP. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration. Brain Pathology (Zurich, Switzerland). PMID 30051532 DOI: 10.1111/Bpa.12631 |
0.536 |
|
| 2018 |
Neddens J, Temmel M, Flunkert S, Kerschbaumer B, Hoeller C, Loeffler T, Niederkofler V, Daum G, Attems J, Hutter-Paier B. Phosphorylation of different tau sites during progression of Alzheimer's disease. Acta Neuropathologica Communications. 6: 52. PMID 29958544 DOI: 10.1186/S40478-018-0557-6 |
0.426 |
|
| 2018 |
Hadar A, Milanesi E, Walczak M, Puzianowska-Kuźnicka M, Kuźnicki J, Squassina A, Niola P, Chillotti C, Attems J, Gozes I, Gurwitz D. SIRT1, miR-132 and miR-212 link human longevity to Alzheimer's Disease. Scientific Reports. 8: 8465. PMID 29855513 DOI: 10.1038/S41598-018-26547-6 |
0.316 |
|
| 2018 |
McAleese KE, Walker L, Colloby SJ, Taylor JP, Thomas AJ, DeCarli C, Attems J. Cortical tau pathology: a major player in fibre-specific white matter reductions in Alzheimer's disease? Brain : a Journal of Neurology. PMID 29668888 DOI: 10.1093/Brain/Awy084 |
0.461 |
|
| 2018 |
Unger MS, Marschallinger J, Kaindl J, Klein B, Johnson M, Khundakar AA, Roßner S, Heneka MT, Couillard-Despres S, Rockenstein E, Masliah E, Attems J, Aigner L. Doublecortin expression in CD8+ T-cells and microglia at sites of amyloid-β plaques: A potential role in shaping plaque pathology? Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29630865 DOI: 10.1016/J.Jalz.2018.02.017 |
0.321 |
|
| 2018 |
Erskine D, Ding J, Thomas AJ, Kaganovich A, Khundakar AA, Hanson PS, Taylor JP, McKeith IG, Attems J, Cookson MR, Morris CM. Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29570843 DOI: 10.1002/Mds.27333 |
0.407 |
|
| 2018 |
Thomas AJ, Mahin-Babaei F, Saidi M, Lett D, Taylor JP, Walker L, Attems J. Improving the identification of dementia with Lewy bodies in the context of an Alzheimer's-type dementia. Alzheimer's Research & Therapy. 10: 27. PMID 29490691 DOI: 10.1186/S13195-018-0356-0 |
0.491 |
|
| 2018 |
Sutovsky S, Smolek T, Turcani P, Petrovic R, Brandoburova P, Jadhav S, Novak P, Attems J, Zilka N. Neuropathology and biochemistry of early onset familial Alzheimer's disease caused by presenilin-1 missense mutation Thr116Asn. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 29404783 DOI: 10.1007/S00702-018-1850-Z |
0.467 |
|
| 2018 |
Gatt A, Ekonomou A, Somani A, Thuret S, Howlett D, Corbett A, Johnson M, Perry E, Attems J, Francis P, Aarsland D, Ballard C. Importance of Proactive Treatment of Depression in Lewy Body Dementias: The Impact on Hippocampal Neurogenesis and Cognition in a Post-Mortem Study. Dementia and Geriatric Cognitive Disorders. 44: 283-293. PMID 29393203 DOI: 10.1159/000484437 |
0.367 |
|
| 2018 |
Attems J, Jellinger K. Proteomics for synaptic markers of cognitive decline in neurodegenerative diseases. Brain : a Journal of Neurology. 141: 329-331. PMID 29390123 DOI: 10.1093/Brain/Awx360 |
0.451 |
|
| 2018 |
Keogh MJ, Wei W, Aryaman J, Wilson I, Talbot K, Turner MR, McKenzie CA, Troakes C, Attems J, Smith C, Al Sarraj S, Morris CM, Ansorge O, Pickering-Brown S, Jones N, et al. Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29332010 DOI: 10.1136/Jnnp-2017-317234 |
0.335 |
|
| 2017 |
Erskine D, Patterson L, Alexandris A, Hanson PS, McKeith IG, Attems J, Morris CM. Regional levels of physiological α-synuclein are directly associated with Lewy body pathology. Acta Neuropathologica. PMID 29134319 DOI: 10.1007/S00401-017-1787-6 |
0.752 |
|
| 2017 |
Thomas AJ, Attems J, Colloby SJ, O'Brien JT, McKeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z. Author response: Autopsy validation of (123)I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology. 89: 751. PMID 28808169 DOI: 10.1212/Wnl.0000000000004254 |
0.4 |
|
| 2017 |
McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, Colloby SJ, Dey M, Martin-Ruiz C, Taylor JP, Thomas AJ, McKeith IG, De Carli C, Attems J. Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease. Acta Neuropathologica. PMID 28638989 DOI: 10.1007/S00401-017-1738-2 |
0.499 |
|
| 2017 |
McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. PMID 28592453 DOI: 10.1212/Wnl.0000000000004058 |
0.404 |
|
| 2017 |
Kovacs GG, Xie SX, Lee EB, Robinson JL, Caswell C, Irwin DJ, Toledo JB, Johnson VE, Smith DH, Alafuzoff I, Attems J, Bencze J, Bieniek KF, Bigio EH, Bodi I, et al. Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG). Journal of Neuropathology and Experimental Neurology. PMID 28591867 DOI: 10.1093/Jnen/Nlx041 |
0.316 |
|
| 2017 |
Spires-Jones TL, Attems J, Thal DR. Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathologica. PMID 28401333 DOI: 10.1007/S00401-017-1709-7 |
0.506 |
|
| 2017 |
Alghamdi A, Vallortigara J, Howlett DR, Broadstock M, Hortobágyi T, Ballard C, Thomas AJ, O'Brien JT, Aarsland D, Attems J, Francis PT, Whitfield DR. Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is associated with Cognitive Impairment in Lewy Body Dementia. Journal of Alzheimer's Disease : Jad. PMID 28269775 DOI: 10.3233/Jad-160946 |
0.488 |
|
| 2017 |
Walker L, McAleese KE, Johnson M, Khundakar AA, Erskine D, Thomas AJ, McKeith IG, Attems J. Quantitative neuropathology: an update on automated methodologies and implications for large scale cohorts. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 28265813 DOI: 10.1007/S00702-017-1702-2 |
0.461 |
|
| 2017 |
Erskine D, Thomas AJ, Taylor JP, Savage MA, Attems J, McKeith IG, Morris CM, Khundakar AA. Neuronal Loss and Α-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 28190674 DOI: 10.1016/J.Jagp.2017.01.005 |
0.306 |
|
| 2017 |
Wei W, Keogh MJ, Wilson I, Coxhead J, Ryan S, Rollinson S, Griffin H, Kurzawa-Akinibi M, Santibanez-Koref M, Talbot K, Turner MR, McKenzie CA, Troakes C, Attems J, Smith C, et al. Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains. Acta Neuropathologica Communications. 5: 13. PMID 28153046 DOI: 10.1186/S40478-016-0404-6 |
0.416 |
|
| 2017 |
Erskine D, Thomas AJ, Attems J, Taylor JP, McKeith IG, Morris CM, Khundakar AA. Specific patterns of neuronal loss in the pulvinar nucleus in dementia with lewy bodies. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28059471 DOI: 10.1002/Mds.26887 |
0.367 |
|
| 2017 |
Attems J. Alzheimer's disease pathology in synucleinopathies. The Lancet. Neurology. 16: 22-23. PMID 27979344 DOI: 10.1016/S1474-4422(16)30282-4 |
0.47 |
|
| 2017 |
Thomas A, Attems J, Colloby SJ, O'Brien JT, McKeith IG, Walker R, Lee L, Burn D, Lett D, Walker Z. Validation By Neuropathology Of Fp-Cit Neuroimaging In Dementia With Lewy Bodies Alzheimers & Dementia. 13: 1462. DOI: 10.1016/J.Jalz.2017.07.530 |
0.393 |
|
| 2017 |
Hortobagyi T, Alghamdi A, Whitfield D, Vallortigara J, Howlett D, Broadstock M, Ballard C, Thomas A, Attems J, Aarsland D, Francis PT. RPT6, 20S α-6 AND α-3 PROTEASOME SUBUNIT LEVELS AND ASSOCIATION WITH COGNITIVE DECLINE IN ALZHEIMER’S DISEASE AND LEWY BODY DEMENTIAS Alzheimers & Dementia. 13: 684. DOI: 10.1016/J.Jalz.2017.06.855 |
0.355 |
|
| 2017 |
McAleese KE, Walker L, Graham S, Erskine D, Moya EL, Johnson M, Colloby SJ, Dey M, Taylor J, Thomas A, McKeith IG, DeCarli CS, Attems J. Parietal White Matter Lesions In Alzheimer’S Disease Are Associated With Cortical Neurodegenerative Pathology And Not With Small-Vessel Disease Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1635 |
0.38 |
|
| 2017 |
Hortobagyi T, Alghamdi A, Vallortigara J, Whitfield D, Howlett DR, Broadstock M, Ballard C, Attems J, Aarsland D, Francis PT. RELATIONSHIP BETWEEN PATHOLOGY SCORES, CLINICAL DATA AND EXPRESSION LEVELS OF PROTEASOME SUB-UNITS IN ALZHEIMER’S DISEASE AND LEWY BODY DEMENTIAS: 2017 Abstract Supplement Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.055 |
0.398 |
|
| 2016 |
Skrobot OA, Attems J, Esiri M, Hortobágyi T, Ironside JW, Kalaria RN, King A, Lammie GA, Mann D, Neal J, Ben-Shlomo Y, Kehoe PG, Love S. Reply: Atherosclerosis and vascular cognitive impairment neuropathological guideline. Brain : a Journal of Neurology. PMID 28007988 DOI: 10.1093/Brain/Aww305 |
0.316 |
|
| 2016 |
Keogh MJ, Wei W, Wilson I, Coxhead J, Ryan S, Rollinson S, Griffin H, Kurzawa-Akanbi M, Santibanez-Koref M, Talbot K, Turner MR, McKenzie CA, Troakes C, Attems J, Smith C, et al. Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource. Genome Research. PMID 28003435 DOI: 10.1101/Gr.210609.116 |
0.386 |
|
| 2016 |
Thomas AJ, Attems J, Colloby SJ, O'Brien JT, McKeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z. Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology. PMID 27940650 DOI: 10.1212/Wnl.0000000000003512 |
0.328 |
|
| 2016 |
Chong JR, Chai YL, Lee JH, Howlett D, Attems J, Ballard CG, Aarsland D, Francis PT, Chen CP, Lai MK. Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load. Journal of Alzheimer's Disease : Jad. PMID 27911312 DOI: 10.3233/Jad-160781 |
0.472 |
|
| 2016 |
Perneczky R, Tene O, Attems J, Giannakopoulos P, Ikram MA, Federico A, Sarazin M, Middleton LT. Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group. Bmc Medicine. 14: 162. PMID 27806707 DOI: 10.1186/S12916-016-0719-Y |
0.437 |
|
| 2016 |
Robinson AC, Palmer L, Love S, Hamard M, Esiri M, Ansorge O, Lett D, Attems J, Morris C, Troakes C, Selvackadunco S, King A, Al-Sarraj S, Mann DM. Extended post-mortem delay times should not be viewed as a deterrent to the scientific investigation of human brain tissue: a study from the Brains for Dementia Research Network Neuropathology Study Group, UK. Acta Neuropathologica. PMID 27638700 DOI: 10.1007/S00401-016-1617-2 |
0.316 |
|
| 2016 |
McAleese KE, Alafuzoff I, Charidimou A, De Reuck J, Grinberg LT, Hainsworth AH, Hortobagyi T, Ince P, Jellinger K, Gao J, Kalaria RN, Kovacs GG, Kövari E, Love S, Popovic M, ... ... Attems J, et al. Post-mortem assessment in vascular dementia: advances and aspirations. Bmc Medicine. 14: 129. PMID 27600683 DOI: 10.1186/S12916-016-0676-5 |
0.513 |
|
| 2016 |
Skrobot OA, Attems J, Esiri M, Hortobágyi T, Ironside JW, Kalaria RN, King A, Lammie GA, Mann D, Neal J, Ben-Shlomo Y, Kehoe PG, Love S. Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment. Brain : a Journal of Neurology. PMID 27591113 DOI: 10.1093/Brain/Aww214 |
0.363 |
|
| 2016 |
Manousopoulou A, Gatherer M, Smith C, Nicoll JA, Woelk CH, Johnson M, Kalaria R, Attems J, Garbis SD, Carare RO. Systems proteomic analysis reveals that Clusterin and Tissue Inhibitor of Metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy. Neuropathology and Applied Neurobiology. PMID 27543695 DOI: 10.1111/Nan.12342 |
0.383 |
|
| 2016 |
McAleese KE, Walker L, Erskine D, Thomas AJ, McKeith IG, Attems J. TDP-43 Pathology in Alzheimer's Disease, Dementia with Lewy Bodies, and Ageing. Brain Pathology (Zurich, Switzerland). PMID 27495267 DOI: 10.1111/Bpa.12424 |
0.496 |
|
| 2016 |
Bereczki E, Francis PT, Howlett D, Pereira JB, Höglund K, Bogstedt A, Cedazo-Minguez A, Baek JH, Hortobágyi T, Attems J, Ballard C, Aarsland D. Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27224930 DOI: 10.1016/J.Jalz.2016.04.005 |
0.468 |
|
| 2016 |
Pirici D, Stanaszek L, Garz C, Niklass S, Heinze HJ, Kalinski T, Attems J, Schreiber S. Common impact of chronic kidney disease and brain microhemorrhages on cerebral Aβ pathology in SHRSP. Brain Pathology (Zurich, Switzerland). PMID 27062392 DOI: 10.1111/Bpa.12384 |
0.448 |
|
| 2016 |
Keogh MJ, Kurzawa-Akanbi M, Griffin H, Douroudis K, Ayers KL, Hussein RI, Hudson G, Pyle A, Cordell HJ, Attems J, McKeith IG, O'Brien JT, Burn DJ, Morris CM, Thomas AJ, et al. Exome sequencing in dementia with Lewy bodies. Translational Psychiatry. 6: e728. PMID 26836416 DOI: 10.1038/Tp.2015.220 |
0.422 |
|
| 2016 |
Niederkofler V, Hoeller C, Neddens J, Auer E, Roemer H, Attems J, Hutter-Paier B. Analysis Of Spatio-Temporal Features Of Histopathology In Murine Alzheimer'S Disease Models And Human Alzheimer'S Disease Samples Alzheimers & Dementia. 12: 1115. DOI: 10.1016/J.Jalz.2016.06.2317 |
0.417 |
|
| 2016 |
Niederkofler V, Temmel M, Lanegger K, Neddens J, Auer E, Attems J, Hutter-Paier B. Characterization Of Vascular Alterations In Human Alzheimer'S Disease Patients In Comparison To The Appsl And 5Xfad Mouse Models Alzheimers & Dementia. 12: 954. DOI: 10.1016/J.Jalz.2016.06.1960 |
0.404 |
|
| 2015 |
Love S, Chalmers K, Ince P, Esiri M, Attems J, Kalaria R, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F, Greenberg S, Mann D, Kehoe PG. Erratum: Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. American Journal of Neurodegenerative Disease. 4: 49. PMID 26807344 |
0.376 |
|
| 2015 |
Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathologica. PMID 26659578 DOI: 10.1007/S00401-015-1509-X |
0.527 |
|
| 2015 |
Vallortigara J, Whitfield D, Quelch W, Alghamdi A, Howlett D, Hortobágyi T, Johnson M, Attems J, O'Brien JT, Thomas A, Ballard CG, Aarsland D, Francis PT. Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia. Journal of Alzheimer's Disease : Jad. PMID 26639969 DOI: 10.3233/Jad-150707 |
0.486 |
|
| 2015 |
Lee C, Low CY, Francis PT, Attems J, Wong PT, Lai MK, Tan MG. An isoform-specific role of FynT tyrosine kinase in Alzheimer's disease. Journal of Neurochemistry. PMID 26561212 DOI: 10.1111/Jnc.13429 |
0.49 |
|
| 2015 |
McAleese KE, Firbank M, Dey M, Colloby SJ, Walker L, Johnson M, Beverley JR, Taylor JP, Thomas AJ, O'Brien JT, Attems J. Cortical tau load is associated with white matter hyperintensities. Acta Neuropathologica Communications. 3: 60. PMID 26419828 DOI: 10.1186/S40478-015-0240-0 |
0.432 |
|
| 2015 |
Keable A, Fenna K, Yuen HM, Johnston DA, Smyth NR, Smith C, Salman RA, Samarasekera N, Nicoll JA, Attems J, Kalaria RN, Weller RO, Carare RO. Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy. Biochimica Et Biophysica Acta. PMID 26327684 DOI: 10.1016/J.Bbadis.2015.08.024 |
0.418 |
|
| 2015 |
Baek JH, Whitfield D, Howlett D, Francis P, Bereczki E, Ballard C, Hortobágyi T, Attems J, Aarsland D. Unfolded protein response is activated in Lewy body dementias. Neuropathology and Applied Neurobiology. PMID 26202523 DOI: 10.1111/Nan.12260 |
0.303 |
|
| 2015 |
Attems J, Walker L, Jellinger KA. Olfaction and Aging: A Mini-Review. Gerontology. PMID 25968962 DOI: 10.1159/000381619 |
0.473 |
|
| 2015 |
Erskine D, Taylor JP, Firbank MJ, Patterson L, Onofrj M, O'Brien JT, McKeith IG, Attems J, Thomas AJ, Morris CM, Khundakar AA. Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies. Neuropathology and Applied Neurobiology. PMID 25967384 DOI: 10.1111/Nan.12249 |
0.335 |
|
| 2015 |
Howlett DR, Attems J, Francis PT. Spreading pathologies precede cognitive decline in Alzheimer's disease. Biological Psychiatry. 77: 678-9. PMID 25835285 DOI: 10.1016/J.Biopsych.2015.02.001 |
0.43 |
|
| 2015 |
Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, Dickson DW, Hof PR, Hyman BT, Jack CR, Jicha GA, Knopman DS, Kovacs GG, Mackenzie IR, Masliah E, et al. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathologica. 129: 757-62. PMID 25778618 DOI: 10.1007/S00401-015-1407-2 |
0.608 |
|
| 2015 |
Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger K, Attems J. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathologica. 129: 729-48. PMID 25758940 DOI: 10.1007/S00401-015-1406-3 |
0.613 |
|
| 2015 |
Spilsbury A, Miwa S, Attems J, Saretzki G. The role of telomerase protein TERT in Alzheimer's disease and in tau-related pathology in vitro. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 1659-74. PMID 25632141 DOI: 10.1523/Jneurosci.2925-14.2015 |
0.396 |
|
| 2015 |
Thal DR, von Arnim CA, Griffin WS, Mrak RE, Walker L, Attems J, Arzberger T. Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 1007-18. PMID 25556950 DOI: 10.1007/S00702-014-1360-6 |
0.543 |
|
| 2015 |
Tiraboschi P, Attems J, Thomas A, Brown A, Jaros E, Lett DJ, Ossola M, Perry RH, Ramsay L, Walker L, McKeith IG. Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load. Neurology. 84: 496-9. PMID 25552579 DOI: 10.1212/Wnl.0000000000001204 |
0.393 |
|
| 2015 |
Howlett DR, Whitfield D, Johnson M, Attems J, O'Brien JT, Aarsland D, Lai MK, Lee JH, Chen C, Ballard C, Hortobágyi T, Francis PT. Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias. Brain Pathology (Zurich, Switzerland). 25: 401-8. PMID 25103200 DOI: 10.1111/Bpa.12182 |
0.493 |
|
| 2015 |
Jellinger KA, Attems J. Challenges of multimorbidity of the aging brain: a critical update. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 505-21. PMID 25091618 DOI: 10.1007/S00702-014-1288-X |
0.604 |
|
| 2015 |
Ekonomou A, Savva GM, Brayne C, Forster G, Francis PT, Johnson M, Perry EK, Attems J, Somani A, Minger SL, Ballard CG. Stage-specific changes in neurogenic and glial markers in Alzheimer's disease. Biological Psychiatry. 77: 711-9. PMID 25022604 DOI: 10.1016/J.Biopsych.2014.05.021 |
0.493 |
|
| 2015 |
Lixie E, Edgeworth J, Shamir L, Blauw GJ, Narici MV, Meskers CGM, Reijnierse EM, Maier AB, Leter MJ, Trappenburg MC, Sipilä S, Sillanpää E, Hogrel J, Butler-Browne G, Schueren MAEdvd, ... ... Attems J, et al. Contents Vol. 61, 2015 Gerontology. 61. DOI: 10.1159/000440820 |
0.332 |
|
| 2015 |
Havas D, Kerschbaumer B, Attems J, Hutter H, Hutter-Paier B, Schweinzer C. P2-187: Tau hyperphosphorylation in Alzheimer's disease: Systematic quantification of common disease-relevant phospho-sites Alzheimer's & Dementia. 11: P563-P564. DOI: 10.1016/J.Jalz.2015.06.726 |
0.441 |
|
| 2015 |
McAleese KE, Firbank M, Dey M, Walker L, Johnson M, McParland S, O'Brien JT, Attems J. P2-184: Cortical hyperphosphorylated tau load is a predictor for white matter lesions in Alzheimer's disease Alzheimer's & Dementia. 11: P562-P563. DOI: 10.1016/J.Jalz.2015.06.723 |
0.412 |
|
| 2014 |
Vallortigara J, Rangarajan S, Whitfield D, Alghamdi A, Howlett D, Hortobágyi T, Johnson M, Attems J, Ballard C, Thomas A, O'Brien J, Aarsland D, Francis P. Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia. F1000research. 3: 108. PMID 25671083 DOI: 10.12688/F1000Research.3786.1 |
0.463 |
|
| 2014 |
Attems J, Neltner JH, Nelson PT. Quantitative neuropathological assessment to investigate cerebral multi-morbidity. Alzheimer's Research & Therapy. 6: 85. PMID 25435922 DOI: 10.1186/S13195-014-0085-Y |
0.382 |
|
| 2014 |
Attems J, Jellinger KA. The overlap between vascular disease and Alzheimer's disease--lessons from pathology. Bmc Medicine. 12: 206. PMID 25385447 DOI: 10.1186/S12916-014-0206-2 |
0.621 |
|
| 2014 |
Bueche CZ, Hawkes C, Garz C, Vielhaber S, Attems J, Knight RT, Reymann K, Heinze HJ, Carare RO, Schreiber S. Hypertension drives parenchymal β-amyloid accumulation in the brain parenchyma. Annals of Clinical and Translational Neurology. 1: 124-9. PMID 25356391 DOI: 10.1002/Acn3.27 |
0.464 |
|
| 2014 |
Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathologica. 128: 755-66. PMID 25348064 DOI: 10.1007/S00401-014-1349-0 |
0.61 |
|
| 2014 |
Veitinger M, Oehler R, Umlauf E, Baumgartner R, Schmidt G, Gerner C, Babeluk R, Attems J, Mitulovic G, Rappold E, Lamont J, Zellner M. A platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotype. Acta Neuropathologica. 128: 665-77. PMID 25248508 DOI: 10.1007/S00401-014-1341-8 |
0.444 |
|
| 2014 |
Thal DR, Attems J, Ewers M. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies. Journal of Alzheimer's Disease : Jad. 42: S421-9. PMID 25227313 DOI: 10.3233/Jad-141461 |
0.52 |
|
| 2014 |
Whitfield DR, Vallortigara J, Alghamdi A, Howlett D, Hortobágyi T, Johnson M, Attems J, Newhouse S, Ballard C, Thomas AJ, O'Brien JT, Aarsland D, Francis PT. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment. Neurobiology of Aging. 35: 2836-44. PMID 25104558 DOI: 10.1016/J.Neurobiolaging.2014.06.015 |
0.462 |
|
| 2014 |
Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB, Dobson-Stone C, Brooks WS, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, ... ... Attems J, et al. Frontotemporal dementia and its subtypes: a genome-wide association study. The Lancet. Neurology. 13: 686-99. PMID 24943344 DOI: 10.1016/S1474-4422(14)70065-1 |
0.323 |
|
| 2014 |
Mandler M, Walker L, Santic R, Hanson P, Upadhaya AR, Colloby SJ, Morris CM, Thal DR, Thomas AJ, Schneeberger A, Attems J. Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's disease. Acta Neuropathologica. 128: 67-79. PMID 24861310 DOI: 10.1007/S00401-014-1296-9 |
0.463 |
|
| 2014 |
Schreiber S, Drukarch B, Garz C, Niklass S, Stanaszek L, Kropf S, Bueche C, Held F, Vielhaber S, Attems J, Reymann KG, Heinze HJ, Carare RO, Wilhelmus MM. Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: longitudinal studies in hypertensive stroke-prone rats. Journal of Alzheimer's Disease : Jad. 42: S205-15. PMID 24825568 DOI: 10.3233/Jad-132618 |
0.463 |
|
| 2014 |
Love S, Chalmers K, Ince P, Esiri M, Attems J, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F, Greenberg S, Mann D, Kehoe PG. Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. American Journal of Neurodegenerative Disease. 3: 19-32. PMID 24754000 |
0.376 |
|
| 2014 |
Attems J, Walker L, Santic R, Colloby S, Upadhaya A, Thal, Schneeberger A, Mandler M. Pyroglutamylated amyloid-beta is associated with hyperphosphorylated tau in human post mortem brains Neuropathology and Applied Neurobiology. 40: 30-30. PMID 24606051 DOI: 10.1111/Nan.12119 |
0.354 |
|
| 2014 |
Attems J, Walker L, Jellinger KA. Olfactory bulb involvement in neurodegenerative diseases. Acta Neuropathologica. 127: 459-75. PMID 24554308 DOI: 10.1007/S00401-014-1261-7 |
0.541 |
|
| 2014 |
McAleese KE, Dey M, Firbank M, McParland S, O'Brien JT, Attems J. P1-319: THE ROLE OF CORTICAL HYPERPHOSPHORYLATED TAU PATHOLOGY IN THE PATHOGENESIS OF WHITE MATTER LESIONS IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P428-P429. DOI: 10.1016/J.Jalz.2014.05.560 |
0.44 |
|
| 2014 |
Walker L, Thomas AJ, Attems J. P1-317: QUANTIFICATION OF PATHOLOGICAL LESIONS DETECTS CLINICOPATHOLOGICAL PHENOTYPES OF MIXED AD/LBD Alzheimer's & Dementia. 10: P428-P428. DOI: 10.1016/J.Jalz.2014.05.558 |
0.368 |
|
| 2014 |
Havas D, Temmel M, Attems J, Hutter H, Hutter-Paier B. Caa In Mutant Ad Mice: A Comparative Study To Human Ad Cases Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.1736 |
0.406 |
|
| 2014 |
Attems J, Walker L, Jellinger KA. O4-09-05: OLFACTORY NEURODEGENERATIVE PATHOLOGY IN NEURODEGENERATIVE DISEASE Alzheimer's & Dementia. 10: P270-P270. DOI: 10.1016/J.Jalz.2014.04.437 |
0.475 |
|
| 2013 |
Thal DR, von Arnim C, Griffin WS, Yamaguchi H, Mrak RE, Attems J, Upadhaya AR. Pathology of clinical and preclinical Alzheimer's disease. European Archives of Psychiatry and Clinical Neuroscience. 263: S137-45. PMID 24077890 DOI: 10.1007/S00406-013-0449-5 |
0.47 |
|
| 2013 |
Attems J, Jellinger KA. Amyloid and tau: neither chicken nor egg but two partners in crime! Acta Neuropathologica. 126: 619-21. PMID 23955601 DOI: 10.1007/S00401-013-1167-9 |
0.511 |
|
| 2013 |
Akinyemi RO, Mukaetova-Ladinska EB, Attems J, Ihara M, Kalaria RN. Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia. Current Alzheimer Research. 10: 642-53. PMID 23627757 DOI: 10.2174/15672050113109990037 |
0.425 |
|
| 2013 |
Attems J, Jellinger K. Neuropathological correlates of cerebral multimorbidity. Current Alzheimer Research. 10: 569-77. PMID 23627751 DOI: 10.2174/15672050113109990002 |
0.622 |
|
| 2013 |
Yamamoto Y, Craggs LJ, Watanabe A, Booth T, Attems J, Low RW, Oakley AE, Kalaria RN. Brain microvascular accumulation and distribution of the NOTCH3 ectodomain and granular osmiophilic material in CADASIL. Journal of Neuropathology and Experimental Neurology. 72: 416-31. PMID 23584202 DOI: 10.1097/Nen.0B013E31829020B5 |
0.329 |
|
| 2013 |
Jellinger KA, Attems J. Neuropathological approaches to cerebral aging and neuroplasticity. Dialogues in Clinical Neuroscience. 15: 29-43. PMID 23576887 |
0.447 |
|
| 2013 |
McAleese KE, Firbank M, Hunter D, Sun L, Hall R, Neal JW, Mann DM, Esiri M, Jellinger KA, O'Brien JT, Attems J. Magnetic resonance imaging of fixed post mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and occipital white matter. Neuropathology and Applied Neurobiology. 39: 485-97. PMID 23075072 DOI: 10.1111/J.1365-2990.2012.01310.X |
0.48 |
|
| 2013 |
Lendvai D, Morawski M, Négyessy L, Gáti G, Jäger C, Baksa G, Glasz T, Attems J, Tanila H, Arendt T, Harkany T, Alpár A. Neurochemical mapping of the human hippocampus reveals perisynaptic matrix around functional synapses in Alzheimer's disease. Acta Neuropathologica. 125: 215-29. PMID 22961619 DOI: 10.1007/S00401-012-1042-0 |
0.335 |
|
| 2013 |
Vallortigara J, Quelch W, Hortobagyi T, Attems J, O'Brien J, Thomas A, Ballard CG, Aarsland D, Francis PT. Synaptic dysfunction and correlations with clinico-pathological features in dementia with Lewy bodies and Parkinson's disease dementia F1000research. 4. DOI: 10.7490/F1000Research.1094082.1 |
0.446 |
|
| 2013 |
Attems J, Walker L, Santic R, Colloby S, Upadhaya AR, Thal D, Schneeberger A, Mandler M. P2-058: Pyroglutamylated beta-amyloid is associated with hyperphosphorylated tau in human post-mortem brains Alzheimer's & Dementia. 9: P364-P364. DOI: 10.1016/J.Jalz.2013.05.701 |
0.355 |
|
| 2013 |
Francis P, Hortobágyi T, Attems J, Aarsland D, Ballard C, O'Brein J, Whitfield D, Alghamdi A, Vallortigara J. P3-041: Contribution of Alzheimer's disease and Lewy body pathology to behavior and cognition in Lewy body dementias Alzheimer's & Dementia. 9: P566-P566. DOI: 10.1016/J.Jalz.2013.05.1110 |
0.438 |
|
| 2012 |
Colloby SJ, McParland S, O'Brien JT, Attems J. Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias. Brain : a Journal of Neurology. 135: 2798-808. PMID 22961551 DOI: 10.1093/Brain/Aws211 |
0.459 |
|
| 2012 |
Jellinger KA, Attems J. Nigral pathology in older persons without Parkinson disease. Annals of Neurology. 72: 297; author reply 29. PMID 22926864 DOI: 10.1002/Ana.23640 |
0.467 |
|
| 2012 |
Attems J, Thal DR, Jellinger KA. The relationship between subcortical tau pathology and Alzheimer's disease. Biochemical Society Transactions. 40: 711-5. PMID 22817721 DOI: 10.1042/Bst20120034 |
0.603 |
|
| 2012 |
Alafuzoff I, Gelpi E, Al-Sarraj S, Arzberger T, Attems J, Bodi I, Bogdanovic N, Budka H, Bugiani O, Englund E, Ferrer I, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, et al. The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium. Experimental Gerontology. 47: 825-33. PMID 22705312 DOI: 10.1016/J.Exger.2012.06.001 |
0.474 |
|
| 2012 |
Thal DR, Grinberg LT, Attems J. Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain. Experimental Gerontology. 47: 816-24. PMID 22705146 DOI: 10.1016/J.Exger.2012.05.023 |
0.455 |
|
| 2012 |
Perry EK, Johnson M, Ekonomou A, Perry RH, Ballard C, Attems J. Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiology of Disease. 47: 155-62. PMID 22504537 DOI: 10.1016/J.Nbd.2012.03.033 |
0.433 |
|
| 2012 |
Jellinger KA, Attems J. Neuropathology and general autopsy findings in nondemented aged subjects. Clinical Neuropathology. 31: 87-98. PMID 22385790 DOI: 10.5414/Np300418 |
0.499 |
|
| 2012 |
Watabe-Rudolph M, Song Z, Lausser L, Schnack C, Begus-Nahrmann Y, Scheithauer MO, Rettinger G, Otto M, Tumani H, Thal DR, Attems J, Jellinger KA, Kestler HA, von Arnim CA, Rudolph KL. Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease. Neurology. 78: 569-77. PMID 22323746 DOI: 10.1212/Wnl.0B013E318247Caa1 |
0.57 |
|
| 2012 |
Zellner M, Baureder M, Rappold E, Bugert P, Kotzailias N, Babeluk R, Baumgartner R, Attems J, Gerner C, Jellinger K, Roth E, Oehler R, Umlauf E. Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients. Journal of Proteomics. 75: 2080-92. PMID 22270014 DOI: 10.1016/J.Jprot.2012.01.014 |
0.537 |
|
| 2012 |
Attems J, Thomas A, Jellinger K. Correlations between cortical and subcortical tau pathology. Neuropathology and Applied Neurobiology. 38: 582-90. PMID 22115520 DOI: 10.1111/J.1365-2990.2011.01244.X |
0.613 |
|
| 2011 |
Jellinger KA, Attems J. Rapidly progressing diffuse Lewy body disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2584-5; author reply. PMID 22038930 DOI: 10.1002/Mds.23976 |
0.452 |
|
| 2011 |
Maj M, Ilhan A, Neziri D, Gartner W, Berggard T, Attems J, Base W, Wagner L. Age related changes in pancreatic beta cells: A putative extra-cerebral site of Alzheimer's pathology. World Journal of Diabetes. 2: 49-53. PMID 21537460 DOI: 10.4239/Wjd.V2.I4.49 |
0.406 |
|
| 2011 |
Lassmann H, Bancher C, Attems J, Paulus W. In honor of the 80th birthday of Kurt Jellinger: a living legend in neuropathology. Acta Neuropathologica. 121: 565-8. PMID 21523431 DOI: 10.1007/S00401-011-0827-X |
0.318 |
|
| 2011 |
Jellinger KA, Attems J. Prevalence and pathology of dementia with Lewy bodies in the oldest old: a comparison with other dementing disorders. Dementia and Geriatric Cognitive Disorders. 31: 309-16. PMID 21502762 DOI: 10.1159/000327360 |
0.59 |
|
| 2011 |
Attems J, Ittner A, Jellinger K, Nitsch RM, Maj M, Wagner L, Götz J, Heikenwalder M. Reduced secretagogin expression in the hippocampus of P301L tau transgenic mice. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 737-45. PMID 21442354 DOI: 10.1007/S00702-011-0626-5 |
0.512 |
|
| 2011 |
Attems J, Jellinger K, Thal DR, Van Nostrand W. Review: sporadic cerebral amyloid angiopathy. Neuropathology and Applied Neurobiology. 37: 75-93. PMID 20946241 DOI: 10.1111/J.1365-2990.2010.01137.X |
0.533 |
|
| 2011 |
Attems J, Ghebremedhin E, Papassotiropoulos A, Saido TC, Griffin WST, Mrak RE, Koelsch H, Tredici KD, Yamaguchi H, Thal D. Capillary CAA defines a subtype of Alzheimer's disease while pericapillary A beta is a type of early A beta deposition Neuropathology and Applied Neurobiology. 37: 9-9. DOI: 10.1111/J.1365-2990.2010.01143.X |
0.32 |
|
| 2011 |
Attems J, Jellinger KA. Pathologic aspects of the hemorrhagic consequences of small vessel disease on the brain Cerebral Small Vessel Disease. 29-41. DOI: 10.1017/CBO9781139382694.005 |
0.427 |
|
| 2011 |
Arnim Cv, Watabe-Rudolph M, Song Z, Schnack C, Begus-Nahrmann Y, Rolyan H, Otto M, Tumani H, Thal D, Attems J, Jellinger K, Kestler H, Rudolph K. Chitinase Enzyme Activity in Cerebral Spinal Fluid is Strongly Associated with Alzheimer’s Disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.836 |
0.418 |
|
| 2010 |
Jellinger KA, Attems J. Prevalence and pathology of vascular dementia in the oldest-old. Journal of Alzheimer's Disease : Jad. 21: 1283-93. PMID 21504129 DOI: 10.3233/Jad-2010-100603 |
0.573 |
|
| 2010 |
Jellinger KA, Attems J. Is there pure vascular dementia in old age? Journal of the Neurological Sciences. 299: 150-4. PMID 20869729 DOI: 10.1016/J.Jns.2010.08.038 |
0.576 |
|
| 2010 |
Attems J, Yamaguchi H, Saido TC, Thal DR. Capillary CAA and perivascular Aβ-deposition: two distinct features of Alzheimer's disease pathology. Journal of the Neurological Sciences. 299: 155-62. PMID 20850138 DOI: 10.1016/J.Jns.2010.08.030 |
0.469 |
|
| 2010 |
Thal DR, Papassotiropoulos A, Saido TC, Griffin WS, Mrak RE, Kölsch H, Del Tredici K, Attems J, Ghebremedhin E. Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease. Acta Neuropathologica. 120: 169-83. PMID 20535486 DOI: 10.1007/S00401-010-0707-9 |
0.469 |
|
| 2010 |
Jellinger KA, Attems J. Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathologica. 119: 421-33. PMID 20204386 DOI: 10.1007/S00401-010-0654-5 |
0.576 |
|
| 2010 |
Maj M, Gartner W, Ilhan A, Neziri D, Attems J, Wagner L. Expression of TAU in insulin-secreting cells and its interaction with the calcium-binding protein secretagogin. The Journal of Endocrinology. 205: 25-36. PMID 20061514 DOI: 10.1677/Joe-09-0341 |
0.366 |
|
| 2009 |
Dimou E, Booij J, Rodrigues M, Prosch H, Attems J, Knoll P, Zajicek B, Dudczak R, Mostbeck G, Kuntner C, Langer O, Bruecke T, Mirzaei S. Amyloid PET and MRI in Alzheimer's disease and mild cognitive impairment. Current Alzheimer Research. 6: 312-9. PMID 19519314 DOI: 10.2174/156720509788486563 |
0.479 |
|
| 2009 |
Jellinger K, Attems J, Lauda F. Sporadic cerebral amyloid angiopathy—No frequent cause of spontaneous brain hemorrhage in the aged Journal of the Neurological Sciences. 283: 274. DOI: 10.1016/J.Jns.2009.02.134 |
0.49 |
|
| 2009 |
Jellinger KA, Attems J. O4-06-06: The impact of vascular and Alzheimer pathologies in Lewy body disease Alzheimer's & Dementia. 5: P163-P164. DOI: 10.1016/J.Jalz.2009.05.563 |
0.533 |
|
| 2009 |
Attems J, Grosinger-Quass M, Nitsch R, Maj M, Wagner L, Jellinger K, Heikenwalder M. O4-03-06: Calcium binding protein Secretagogin expression in wild type and transgenic tau (P301L) mice Alzheimer's & Dementia. 5: P155-P155. DOI: 10.1016/J.Jalz.2009.05.536 |
0.404 |
|
| 2009 |
Elisabeth K, Jellinger KA, Janetzky B, Attems J, Missbichler A, Stachelberger H. P4-146: New aspects of membrane breakdown in Alzheimer's disease brain Alzheimer's & Dementia. 5: P474-P474. DOI: 10.1016/J.Jalz.2009.04.814 |
0.502 |
|
| 2009 |
Maj M, Wagner L, Ilhan A, Jellinger K, Heikenwalder M, Attems J. P3-196: The four repeat tau isoform 5 represents a calcium-dependent interaction partner of secretagogin (SCGN) Alzheimer's & Dementia. 5: P400-P400. DOI: 10.1016/J.Jalz.2009.04.1070 |
0.413 |
|
| 2008 |
Jellinger KA, Janetzky B, Attems J, Kienzl E. Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker? Journal of Cellular and Molecular Medicine. 12: 1094-117. PMID 18363842 DOI: 10.1111/J.1582-4934.2008.00313.X |
0.575 |
|
| 2008 |
Jellinger KA, Attems J. Cerebral amyloid angiopathy in Lewy body disease. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 473-82. PMID 18301958 DOI: 10.1007/S00702-007-0856-8 |
0.556 |
|
| 2008 |
Attems J, Jellinger KA. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease. Neuropathology and Applied Neurobiology. 34: 466-7. PMID 18282157 DOI: 10.1111/J.1365-2990.2008.00937.X |
0.421 |
|
| 2008 |
Jellinger KA, Attems J. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathologica. 115: 427-36. PMID 18273624 DOI: 10.1007/S00401-008-0347-5 |
0.605 |
|
| 2008 |
Attems J, Lauda F, Jellinger KA. Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study. Journal of Neurology. 255: 70-6. PMID 18202817 DOI: 10.1007/S00415-008-0674-4 |
0.575 |
|
| 2008 |
Attems J, Preusser M, Grosinger-Quass M, Wagner L, Lintner F, Jellinger K. Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease. Neuropathology and Applied Neurobiology. 34: 23-32. PMID 17961140 DOI: 10.1111/J.1365-2990.2007.00854.X |
0.564 |
|
| 2008 |
Jellinger KA, Attems J. The role of vascular and Alzheimer pathologies in Lewy body disease | Die rolle von vaskulären und Alzheimerläsionen bei Lewy-körper-krankheiten Journal Fur Neurologie, Neurochirurgie Und Psychiatrie. 9: 7-10. |
0.35 |
|
| 2007 |
Jellinger KA, Lauda F, Attems J. Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 14: 923-8. PMID 17662016 DOI: 10.1111/J.1468-1331.2007.01880.X |
0.582 |
|
| 2007 |
Jellinger KA, Attems J. Neuropathological evaluation of mixed dementia. Journal of the Neurological Sciences. 257: 80-7. PMID 17324442 DOI: 10.1016/J.Jns.2007.01.045 |
0.587 |
|
| 2007 |
Attems J, Quass M, Jellinger KA, Lintner F. Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology. Journal of the Neurological Sciences. 257: 49-55. PMID 17306303 DOI: 10.1016/J.Jns.2007.01.013 |
0.598 |
|
| 2007 |
Attems J, Quass M, Gartner W, Nabokikh A, Wagner L, Steurer S, Arbes S, Lintner F, Jellinger K. Immunoreactivity of calcium binding protein secretagogin in the human hippocampus is restricted to pyramidal neurons. Experimental Gerontology. 42: 215-22. PMID 17116382 DOI: 10.1016/J.Exger.2006.09.018 |
0.473 |
|
| 2007 |
Jellinger KA, Attems J. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathologica. 113: 107-17. PMID 17089134 DOI: 10.1007/S00401-006-0156-7 |
0.611 |
|
| 2007 |
Attems J, Quass M, Jellinger KA. Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs. Acta Neuropathologica. 113: 53-62. PMID 17031655 DOI: 10.1007/S00401-006-0146-9 |
0.594 |
|
| 2006 |
Attems J, Jellinger KA. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Clinical Neuropathology. 25: 265-71. PMID 17140156 |
0.53 |
|
| 2006 |
Jellinger KA, Attems J. Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathologica. 112: 253-60. PMID 16804711 DOI: 10.1007/S00401-006-0088-2 |
0.597 |
|
| 2006 |
Jellinger KA, Attems J. Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism. Acta Neurologica Scandinavica. 114: 38-46. PMID 16774626 DOI: 10.1111/J.1600-0404.2006.00665.X |
0.618 |
|
| 2006 |
Attems J, Jellinger KA. Hippocampal sclerosis in Alzheimer disease and other dementias. Neurology. 66: 775. PMID 16534130 DOI: 10.1212/01.Wnl.0000200959.50898.26 |
0.573 |
|
| 2006 |
Kienzl E, Jellinger KA, Janetzky B, Attems J, Dal-Bianco P, Stachelberger H. P1-367: Nested gene and autoimmune response in Alzheimer's disease Alzheimer's & Dementia. 2: S205-S205. DOI: 10.1016/J.Jalz.2006.05.745 |
0.5 |
|
| 2006 |
Attems J, Quass M, Gartner W, Wagner L, Jellinger KA, Lintner F. P3-183: Cellular immunoreactivity of calcium-binding protein secretagogin in human hippocampus is restricted to pyramidal neurons Alzheimer's & Dementia. 2: S428-S428. DOI: 10.1016/J.Jalz.2006.05.1451 |
0.391 |
|
| 2006 |
Jellinger KA, Attems J, Quass M, Lintner F. O2-01-04: Tau and alpha-synuclein brainstem pathology in Alzheimer disease Alzheimer's & Dementia. 2: S30-S30. DOI: 10.1016/J.Jalz.2006.05.105 |
0.517 |
|
| 2006 |
Quass M, Attems J, Jellinger KA, Lintner F. O1-01-03: Alzheimer disease pathology influences the impact of cerebral amyloid angiopathy on cognitive decline Alzheimer's & Dementia. 2: S8-S8. DOI: 10.1016/J.Jalz.2006.05.036 |
0.548 |
|
| 2005 |
Attems J. Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathologica. 110: 345-59. PMID 16170565 DOI: 10.1007/S00401-005-1074-9 |
0.477 |
|
| 2005 |
Attems J, König C, Huber M, Lintner F, Jellinger KA. Cause of death in demented and non-demented elderly inpatients; an autopsy study of 308 cases. Journal of Alzheimer's Disease : Jad. 8: 57-62. PMID 16155350 DOI: 10.3233/Jad-2005-8107 |
0.58 |
|
| 2005 |
Attems J, Jellinger KA, Lintner F. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathologica. 110: 222-31. PMID 16133541 DOI: 10.1007/S00401-005-1064-Y |
0.606 |
|
| 2005 |
Attems J, Lintner F, Jellinger KA. Olfactory involvement in aging and Alzheimer's disease: an autopsy study. Journal of Alzheimer's Disease : Jad. 7: 149-57; discussion 1. PMID 15851853 DOI: 10.3233/Jad-2005-7208 |
0.574 |
|
| 2005 |
Jellinger KA, Attems J. Alzheimer pathology in the olfactory bulb. Neuropathology and Applied Neurobiology. 31: 203. PMID 15771713 DOI: 10.1111/J.1365-2990.2004.00619.X |
0.485 |
|
| 2005 |
Jellinger KA, Attems J. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. Journal of the Neurological Sciences. 229: 37-41. PMID 15760617 DOI: 10.1016/J.Jns.2004.11.018 |
0.603 |
|
| 2004 |
Attems J, Arbes S, Böhm G, Böhmer F, Lintner F. The clinical diagnostic accuracy rate regarding the immediate cause of death in a hospitalized geriatric population; an autopsy study of 1594 patients. Wiener Medizinische Wochenschrift (1946). 154: 159-62. PMID 15182042 DOI: 10.1007/S10354-004-0057-0 |
0.301 |
|
| 2004 |
Attems J, Lintner F, Jellinger KA. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathologica. 107: 283-91. PMID 14986026 DOI: 10.1007/S00401-004-0822-6 |
0.554 |
|
| 2004 |
Attems J, Jellinger KA. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study. Acta Neuropathologica. 107: 83-90. PMID 14655019 DOI: 10.1007/S00401-003-0796-9 |
0.589 |
|
| 2004 |
Attems J, Lintner F, Jellinger KA. O2-04-04 Relations between cerebral amyloid angiopathy and Alzheimer's disease pathology Neurobiology of Aging. 25: S39. DOI: 10.1016/S0197-4580(04)80130-1 |
0.557 |
|
| 2004 |
Attems J, Lintner F, Jellinger K. [correction] Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology (vol 107, pg 283, 2004) Acta Neuropathologica. DOI: 10.1007/S00401-004-0866-7 |
0.521 |
|
| 2003 |
Jellinger KA, Attems J. Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study. Acta Neuropathologica. 105: 14-7. PMID 12471455 DOI: 10.1007/S00401-002-0634-5 |
0.592 |
|
| Show low-probability matches. |